Camurus AB

Common Name

Camurus

Country

Sweden

Sector

Healthcare

Industry

Biotechnology

Employees

267

Ticker

CAMX

Exchange

NASDAQ STOCKHOLM AB

Website

www.camurus.com

Description

Camurus AB is a research-based pharmaceutical company focused on developing and commercializing innovative and effective medicines. The company's primary focus is on addressing significant unmet medic... Show more

Income Statement Balance Sheet Group Entities

Camurus's Financial Statements Preview

Below are the financial statements of Camurus, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of SEK	2024 as of 2024-12-31	2023 as of 2023-12-31
Assets	—	—
Fixed assets	—	—
Intangible assets	—	—
Capitalized development expenditure	22.72^a	22.75^a
Tangible assets	—	—
Lease asset	16.85^a	24.01^a
Equipment	40.89^a	15.67^a
Financial assets	—	—
Other long-term receivables	1.56^a	1.41^a
Deferred tax receivables	125.87^a	219.91^a
Total fixed assets	207.9^a	283.75^a
Current assets	—	—
Inventories	—	—
Finished goods and goods for sale	140.22^a	100.96^a
Current receivables	—	—
Trade receivables	416.34^a	274.07^a
Other receivables	25.99^a	26.7^a
Prepayments and accrued income	113.86^a	32.51^a
Total current receivables	556.19^a	333.27^a
Cash and cash equivalents	2,852.7^a	1,189.84^a
Total current assets	3,549.12^a	1,624.07^a
Total assets	3,757.01^a	1,907.82^a
Equity and liabilities	—	—
Equity	—	—
Equity attributable to parent company shareholders	—	—
Share capital	1.47^a	1.39^a
Other contributed capital	3,408.06^a	2,042.5^a
Other reserves	5.2^a	2.48^a
Retained earnings, including result for the year	-125.05^a	-553.37^a
Total equity	3,289.68^a	1,493^a
Liabilities	—	—
Long-term liabilities	—	—
Lease liablities	7.14^a	13.61^a
Social security fees employee stock options programs	21.57^a	32.61^a
Total long-term liabilities	28.71^a	46.23^a
Short-term liabilities	—	—
Trade payables	118.25^a	99.28^a
Lease liabilities	9.91^a	10.89^a
Income taxes	15.27^a	11.28^a
Social security fees employee stock options programs	52.84^a	46.82^a
Other liabilities	49.88^a	33.45^a
Accrued expenses and deferred income	192.48^a	166.87^a
Total short-term liabilities	438.63^a	368.59^a
Total equity and liabilities	3,757.01^a	1,907.82^a

Download Data

Verified Sources Behind Camurus’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Camurus’s data sources below and access millions more through our Disclosure Search.

a. Camurus's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Camurus AB

Camurus's Financial Statements Preview

Verified Sources Behind Camurus’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

SpringWorks Therapeutics Inc

Alteogen Inc

BridgeBio Pharma Inc

Ultragenyx Pharmaceutical Inc

Zealand Pharma A/S

Pharmaron Beijing Co Ltd